IL17A and metabolic dysfunction-associated steatotic liver disease: Specific genetic polymorphisms (SNPs) in IL17A/F, especially G7488A and G197A, have been correlated with the modulation of systemic inflammation and fibrosis in NAFLD, influencing genetic susceptibility to MASLD [39].